Instruction for use: UPSAVIT Calcium

Active substance Calcium carbonate

ATX Code A12AA04 Calcium carbonate

Pharmacological group

Macro and microelements

Nosological classification (ICD-10)

E55.0 Rickets active

Vitamin D-dependent rickets, Congenital vitamin D-resistant rickets, Late rickets, Pseudo-deficiency rickets, Rickets, Rickets Vitamin D-dependent, Rickets of newborns, Rasmic spasmophilia

E58 Alimentary calcium deficiency

Replenishment of calcium deficiency, Replenishment of calcium deficiency in the body, Replenishment of a lack of calcium, Calcium deficiency, Calcium deficiency in the mother's body, Deficiency of calcium and vitamin D3, Deficiency of calcium and vitamin D3 in the elderly,Calcium and magnesium deficiency in breastfeeding, Calcium deficiency in pregnant women, An additional source of calcium, An additional source of calcium and phosphorus, Source of calcium, Correction of calcium metabolism disorders during pregnancy, Lack of calcium, Lack of calcium in the diet, Lack of calcium in the body, Inadequate intake of calcium from food, Insufficiency of calcium, Increased need for calcium, Increased need for calcium in breastfeeding

E83.5.1 * Hypocalcemia

Spasmophilia, Hypocalcemia of iatrogenic nature, Secondary hypocalcemia

M81.0 Postmenopausal osteoporosis

Menopause osteoporosis, Osteoporosis in menopause, Osteoporosis in menopause, Osteoporosis in postmenopausal women, Osteoporosis in the postmenopausal period, Postmenopausal osteoporosis, Osteoporosis in postmenopausal women, Perimenopausal osteoporosis, Postmenopausal osteoporosis, Post-menopausal osteoporosis, Postmenopausal osteoporosis, Postmenopausal demineralization of bones, Osteoporosis with estrogen deficiency, Osteoporosis in postmenopausal women, Osteoporosis in postmenopausal women and after hysterectomy

M81.9 Other specified osteoporosis

Osteoporosis due to androgen deficiency, Primary osteoporosis, Osteoporosis in men, Parathyroid osteoporosis, Primary osteoporosis, Post-traumatic osteoporosis, Loss of calcium in bones and teeth, Presennial osteoporosis, Systemic osteoporosis

M83 Osteomalacia in adults

Osteolysis, Osteomalacia, English Disease

O25 Malnutrition in pregnancy

Hypovitaminosis during pregnancy, Deficiency of vitamins and minerals in pregnancy, Deficiency of iron and folic acid in pregnancy, Iron deficiency in women during pregnancy, Iodine deficiency in pregnancy, Iodine deficiency in lactating women, Calcium deficiency in the mother's body, Calcium deficiency in pregnant women, Mineral deficiency during pregnancy, An additional source of folic acid during pregnancy, Correction of calcium metabolism disorders during pregnancy, Lack of iron during pregnancy and lactation, Pregnancy Period, Breastfeeding period, Increased need for vitamin B1 in pregnancy

R29.0 Theta

Latent tetany

T78.4 Allergy, unspecified

Allergic reactions to insulin, Allergic reactions to insect stings, Allergic reactions similar to systemic lupus erythematosus, Allergic diseases, Allergic diseases of mucous membranes, Allergic diseases and conditions resulting from increased release of histamine, Allergic diseases of mucous membranes, Allergic symptoms, Allergic symptoms in the mucous membranes, Allergic reactions, Allergic reactions caused by insect bites, Allergic reactions, Allergic conditions, Allergic laryngeal edema, allergopathy, allergic conditions, Allergy, House dust allergy, Anaphylaxis, Cutaneous reactions to medications, Skin reaction to insect stings, Cosmetic allergy, Drug allergy, Acute allergic reaction, Laryngeal edema allergic genesis and background radiation, Food and drug allergy

Composition and form of release

1 effervescent tablet contains calcium carbonate 1250 mg (corresponding to 500 mg of calcium); in a tube 20 pcs., in a box 1 tuba.

pharmachologic effect

Pharmacological action - replenishing calcium deficiency.

Inhibits the activity of osteoclasts and inhibits the resorption of bone tissue.

Indication

The increased need of the body for calcium (pregnancy, breast-feeding, the period of active growth), osteoporosis, incl. postmenopausal (prevention and treatment); rickets, osteomalacia, tetany, allergic reactions (auxiliaries).

Contraindications

Hypersensitivity; hypercalcemia (hyperparathyroidism, vitamin D overdose, bone metastases), multiple myeloma, sarcoidosis, marked renal failure, pronounced hypercalciuria.

Side effects

Dyspeptic phenomena: pain in epigastrium, flatulence, diarrhea, constipation.

Interaction

Reduces absorption in the gastrointestinal tract of tetracyclines (a spacing of at least 3 hours is required). Strengthens the cardiotoxic effect of cardiac glycosides. When administered simultaneously with sodium fluoride, it forms poorly digestible calcium fluoride.

Dosing and Administration

Inside, dissolving in a glass of water.

Adults: 1 table. 2-3 times a day; osteoporosis: the initial dose is 2 tablets. 2 times / day, after a few weeks the dose is reduced to normal.

Children: 1 table / day, with a pronounced lack of calcium in the body - 1 table. 2-3 times / day.

Precautionary measures

When administered concomitantly with vitamin D, the dosage should not exceed 2 tablets. per day. With urolithiasis, chronic renal failure and hypercalciuria should only be taken under the supervision of a doctor (control of the amount of calcium excreted in urine is necessary).

storage Conditions

In a dry, the dark place at a temperature of no higher than 30 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiry date printed on the package.